Celltrion | 068270 - Eigenkapital Und Reserven

Aktienkurs
198,400.00
Täglich Wechseln
8,800.00 4.64%
Monatlich
-3.69%
Jährlich
29.93%
Q2 Prognose
177,698.56




Eigenkapital Und Reserven Veränderung Datum
Akebia Therapeutics USD 27.38M 5.24M 2026-03
Alaunos Therapeutics USD 1.29M 865K 2026-03
Avita Medical AUD -16.65M 3.76M 2025-12
Celltrion KRW 435.96B 16.26T 2025-12
Dianthus Therapeutics USD 1.2B 707.91M 2026-03
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
IQVIA Holdings USD 6.22B 282M 2026-03
Moderna USD 7.41B 1.24B 2026-03
Organon & Co USD 903M 151M 2026-03
Revvity USD 7.25B 125.54M 2025-12
Tectonic Therapeutic USD 230.42M 20.91M 2026-03
Viatris USD 14.66B 53.6M 2026-03
Xeris Pharmaceuticals USD 13.01M 678K 2026-03